This 3-day conference has become the first major, non-commercial scientific forum devoted exclusively to the presentation and sharing of data and knowledge among the diverse disciplines of vaccinology. It serves as an annual forum for presenting and discussing the latest vaccine-related scientific data, results, and issues via symposia and panel discussions by expert faculty and through oral and poster presentations of submitted papers. The goal is to encourage communication among vaccine researchers and developers, public health officials, and medical personnel who administer vaccines.

• Keynote Address: Nobel Laureate Peter C. Doherty, Ph.D.
• Vaccines for Major World Diseases: AIDS, Malaria, Tuberculosis
  • Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences
• Therapeutic Vaccines
• Genetic Determinants of Vaccine Immune Response
• Vaccines Against Candidate Bioterrorist Agents
• Clinical Trials in Developing Countries: What Are the Issues?
• Antigen Processing and Presentation

Vaccines for Major World Diseases: AIDS, Malaria, Tuberculosis

• Discuss one general approach to new vaccine discovery.
• Discuss the status of one candidate vaccine for two of the following diseases: tuberculosis, malaria, and/or human immunodeficiency virus.

• Identify at least three therapeutic vaccine candidates.
• Discuss the proposed mechanism of action of at least one therapeutic vaccine candidate undergoing clinical trials.

• Discuss the interaction of Class I and Class II HLA genes on hepatitis B vaccine response.
• Discuss the influence of Gm and Km allotypes on pneumococcal and Hib vaccine antibody responses.

• Identify at least three biological agents or their toxins which pose serious and realistic threats as biological weapons.
• Discuss efforts to develop a vaccine for at least one potential biological weapon. Include in the discussion at least one major pitfall in vaccine development for this agent.

• Identify and discuss at least two ethical issues in designing and implementing clinical vaccine trials in developing countries.
• Identify and discuss at least two logistical or methodological problems in conducting clinical vaccine trials in developing countries.

• Using one model, discuss the biochemistry of antigen processing.
• Identify the mechanism and role of antigen presentation in the immune response.

• Researchers and Scientists
• Epidemiologists
• Microbiologists
• Immunologists
• Molecular Biologists
• Public Health Officials
• Physicians and Veterinarians
• Vaccine Manufacturers

Continuing education credit has been applied for, based on 12 hours of instruction.

• Back to NFID-SPONSORED CONFERENCES